Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials.
Saved in:
| Title: | Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials. |
|---|---|
| Authors: | Khan, Adam1 (AUTHOR) adam.khan@okstate.edu, Khan, Hassan1 (AUTHOR), Hughes, Griffin K.1 (AUTHOR), Ladd, Chase1 (AUTHOR), McIntire, Ryan1 (AUTHOR), Gardner, Brooke1 (AUTHOR), Peña, Andriana M.1 (AUTHOR), Schoutko, Abigail2 (AUTHOR), Tuia, Jordan3 (AUTHOR), Minley, Kirstien1 (AUTHOR), Haslam, Alyson3 (AUTHOR), Prasad, Vinay3 (AUTHOR), Vassar, Matt1,4 (AUTHOR) |
| Source: | Cancer Medicine. May2024, Vol. 13 Issue 9, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.7130 |